- Home
- CCBG vs EYPT Comparison
CCBG vs EYPT Comparison
Compare CCBG & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCBG
- EYPT
- Stock Information
- Founded
- CCBG 1895
- EYPT 1987
- Country
- CCBG United States
- EYPT United States
- Employees
- CCBG N/A
- EYPT N/A
- Industry
- CCBG Major Banks
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- CCBG Finance
- EYPT Industrials
- Exchange
- CCBG Nasdaq
- EYPT Nasdaq
- Market Cap
- CCBG 620.5M
- EYPT 594.5M
- IPO Year
- CCBG N/A
- EYPT 2005
- Fundamental
- Price
- CCBG $35.85
- EYPT $8.72
- Analyst Decision
- CCBG Buy
- EYPT Strong Buy
- Analyst Count
- CCBG 3
- EYPT 8
- Target Price
- CCBG $38.50
- EYPT $25.71
- AVG Volume (30 Days)
- CCBG 27.6K
- EYPT 888.8K
- Earning Date
- CCBG 01-28-2025
- EYPT 03-06-2025
- Dividend Yield
- CCBG 2.46%
- EYPT N/A
- EPS Growth
- CCBG 3.04
- EYPT N/A
- EPS
- CCBG 3.04
- EYPT N/A
- Revenue
- CCBG $226,023,000.00
- EYPT $45,713,000.00
- Revenue This Year
- CCBG N/A
- EYPT N/A
- Revenue Next Year
- CCBG $3.63
- EYPT N/A
- P/E Ratio
- CCBG $11.77
- EYPT N/A
- Revenue Growth
- CCBG 4.47
- EYPT 7.50
- 52 Week Low
- CCBG $25.45
- EYPT $6.90
- 52 Week High
- CCBG $40.86
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- CCBG 46.39
- EYPT 56.13
- Support Level
- CCBG $35.04
- EYPT $7.15
- Resistance Level
- CCBG $36.85
- EYPT $8.25
- Average True Range (ATR)
- CCBG 0.94
- EYPT 0.70
- MACD
- CCBG 0.15
- EYPT 0.07
- Stochastic Oscillator
- CCBG 65.37
- EYPT 68.92
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.